Drugs / EMOXYPINE
EMOXYPINE
also known as
Mexidol · Ethyl methyl hydroxypyridine succinate · Mexidol FORTE 250 · Emicidin · Emicidine · Emoxipin · Emoxipine · Emoxypin · +9 more
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT06437626 | Nov 2019 → Aug 2023 | ischemic stroke | Pharmasoft | Completed | No outcome recorded |
| Phase 3 | NCT02793687 | Mar 2015 → May 2016 | ischemic stroke | Pharmasoft | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT07575984 | Nov 2025 → Apr 2027 expected | ischemic stroke | Pharmasoft | Recruiting | No outcome recorded |
| Phase 4 | NCT07700615 | Sep → Nov 2025 | cognitive impairment with or without cerebellar ataxia | Pharmasoft | Completed | No outcome recorded |
| Phase 4 | NCT06221826 | Apr → Sep 2023 | ischemic stroke | Pharmasoft | Completed | No outcome recorded |
| Phase 4 | NCT05939622 | May → Dec 2022 | COVID-19, cognitive disorder, neurocirculatory asthenia | Promomed, LLC | Completed | No outcome recorded |
| Phase 4 | NCT05689827 | Apr → Nov 2022 | COVID-19 | Promomed, LLC | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06903156 Comparator | Nov 2021 → Sep 2023 | open-angle glaucoma | Pharmasoft | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06834490 Comparator | Nov 2019 → Dec 2020 | brain ischemia | Pharmasoft | Completed | No outcome recorded |
| Phase 3 | NCT06854601 Comparator | Jul 2019 → Jul 2020 | anxiety disorder, attention deficit-hyperactivity disorder | Pharmasoft | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06437639 Comparator | Sep → Nov 2023 | open-angle glaucoma | Pharmasoft | Completed | No outcome recorded |
Evidence & citations 20 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMOXYPINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Emicidin | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Emicidine | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Emoxipin | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Emoxipine | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Emoxypin | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | EMOXYPINE SUCCINATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Epigid | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Epygid | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Ethyl methyl hydroxypyridine succinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05939622 ↗ |
| Known as | Ethylmethylhydroxypyridine | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Methylethylpiridinol | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Methylethylpiridinol succinate | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Mexicor | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Known as | Mexidol | “Mexidol (Ethylmethylhydroxypyridine Succinate)” NCT06437626 ↗ |
| Known as | Mexidol FORTE | “Oral administration of Mexidol® FORTE 250 mg tablets, 1 tablet 3 times daily” NCT07700615 ↗ |
| Known as | Mexidol FORTE 250 | “Participants received Mexidol IV 500 mg (10 ml) once daily for 14 days, then Mexidol FORTE 250 orally 250 mg 1 tablet 3 times a day for 60 days” NCT06834490 ↗1“Phase 2 (Days 11-70): Mexidol® FORTE 250 film-coated tablets, 250 mg three times daily (total daily dose 750 mg) for 60 days.” NCT07575984 ↗ |
| Known as | Mexiprim | ChEMBL registry synonym — accepted as the source's own label CHEMBL3338326 ↗ |
| Modality | Small molecule | — CHEMBL3338326 ↗ |
| Route | Intravenous | “Participants received Mexidol® solution IV 500 mg daily for 10 days” NCT02793687 ↗ |